Nomination deadline for Gruber Gentics and Neuroscience Prizes is Dec. 15

Genetics Prize

The unrestricted $500,000 prize is presented to a leading scientist, or group of scientists (up to three), in recognition of groundbreaking contributions to any realm of genetics research. These contributions may include original discoveries in genetic function, regulation, transmission, and variation, as well as in genomic organization. Nominations may be submitted by individuals, organizations, and institutions that are active in or have an appreciation for contemporary genetic research or problems.

Neuroscience Prize

This unrestricted cash award of $500,000 is awarded each year to a person or persons chosen by a distinguished advisory board of neuroscience experts from nominations that are received from around the world. Nominations for this prize are invited annually and may be submitted by individuals, organizations, and institutions that are active in or have an appreciation for contemporary neuroscience research and study. Individuals from anywhere in the world who have conducted highly distinguished research in the field of the brain, spinal cord, or peripheral nervous system may be nominated.

The nomination deadline for both the Neuroscience and Genetics Prizes is December 15, 2014.

TTBD announces 2014 award winners

On Monday, October 6, Technology Transfer and Business Development (TTBD) hosted the 2014 TTBD Awards to recognize OHSU researchers who had technologies licensed or optioned in the last fiscal year as well as those who brought in top dollars from industry to support their research. The ceremony drew an enthusiastic crowd to the Portland State University lecture hall at the new Collaborative Life Sciences Building.

We’d like to congratulate all of the researchers who were recognized at this year’s Innovation Awards ceremony, including:

Technology Transfer Achievement Award: Arthur Vandenbark, PhD

Dr. Vandenbark is a Professor of MMI and Neurology at OHSU and a Senior Research Career Scientist at the VAMC. He is the Co-Director of the Neuroimmunology Program that is focused on the development and translation of novel therapeutic immunoregulatory and neuroprotective agents for treatment of multiple sclerosis and other autoimmune and inflammatory diseases of the central nervous system. Since 1999, Dr. Vandenbark has disclosed 27 new inventions to Technology Transfer, 11 of which are exclusively licensed. He is also an inventor on 15 issued US patents and has collaborated with industry on several research studies.

New Inventor of the Year Award: Michael P. Hutchens, M.D., M.A.

Dr. Hutchens serves as Associate Professor in the Department of Anesthesiology & Perioperative Medicine and is a critical care physician in the Knight Cardiovascular Intensive Care Unit. Dr. Hutchens is the recipient of a NIDDK-funded K08 grant for his research focusing on sex and acute kidney injury. Dr. Hutchens is also the recipient of an OHSU Biomedical Innovation Program Award. OHSU has filed patents on two of Dr. Hutchens’ nine disclosed inventions, one of which is exclusively optioned to a company for evaluation. Dr. Hutchens’ inventions thus far focus on bringing smart, reliable technology to the patient as wearable or bedside devices to improve safety.

Business Partnership Achievement Award: Sanjiv Kaul, M.D.

Dr. Kaul is currently the Ernest C. Swigert Chair of Cardiovascular Medicine, Professor of Medicine and Radiology, CEO of the Knight Cardiovascular Institute and Associate Dean, School of Medicine at OHSU. His major clinical and research interest is coronary artery disease. He is a pioneer in cardiovascular imaging, having spearheaded many of the developments in contrast echocardiography and making major contributions to the field of nuclear cardiology.


TTBD also recognized the hard work of the OHSU Office of Proposal and Award Management with an award of appreciation.


Peter Barr-Gillespie and Kateri Spinelli win BioArt Competition

Chick sensory hair cells

The winning image

Dr. Peter Barr-Gillespie, Ph.D, and Kateri Spinelli, Ph.D. are one of 12 winners of the 2014 Federation of American Societies for Experimental Biology (FASEB) annual BioArt competition. Their submission, showing the sensory hair cells of a chick, was captured by scanning electron microscopy. The image comes from joint work to discover better methods to detect and treat hearing loss and disrupted balance.

The 12 winning images and videos demonstrate the breadth of ongoing research in the biomedical and life sciences. Winning entries were unveiled on FASEB’s website and will be exhibited at the National Institutes of Health. The BioArt competition is open to members of FASEB constituent societies and biomedical and life scientists whose research is supported by federal funds. More information about the competition can be found on the BioArt website.


Winter deadlines for American Heart research grants and fellowships

The American Heart Association has announced its winter deadlines for a wide range of funding opportunities relating to cardiovascular disease and stroke. All proposals and applications will be due either January 15th or 22nd, 2015.

American Heart Association – Winter 2015 Funding Opportunities

  • Pre-Doctoral Fellowship – $25,000 per year for one or two years to help students begin careers in cardiovascular or stroke related  research by providing research assistance and training. Research should be broadly related to cardiovascular function and disease and stroke, or to related clinical, basic science, bioengineering or biotechnology, and public health problems, including multidisciplinary efforts.
  • Postdoctoral Fellowship – $40,000-$50,000 per year for up to two years. This opportunity is intended to help trainees initiate careers in cardiovascular and stroke research while obtaining significant research results under the supervision of a sponsor or mentor; supports individuals before they are ready for some stage of independent research.
  • Beginning Grant-in-Aid – Up to $70,000 per year for up to two years to promote the independent status of promising beginning scientists. Research should be broadly related to cardiovascular function and disease and stroke, or related clinical, basic science, bioengineering or biotechnology, and public health problems, including multidisciplinary efforts.
  • Grant-in-Aid – Up to $70,000 per year for up to two years to fund the most innovative and meritorious research projects from independent investigators. Research must be broadly related to cardiovascular function and disease and stroke, or to clinical, basic science, bioengineering or biotechnology, and public health problems.
  • Mentored Clinical and Population Research Award – Up to $75,000 per year for up to two years to encourage early investigators who have appropriate and supportive mentoring relationships to engage in high quality introductory and pilot clinical studies that will guide future strategies for reducing cardiovascular disease and stroke while fostering new research in clinical and translational science, and encouraging community and population-based activities.
  • National Scientist Development Grant – Up to $77,000 per year for up to four years to support beginning scientists in their progress toward independence by funding research projects that can bridge the gap between completion of research training and readiness for a successful career as an independent investigator.

View the rest of this weeks Funding Alerts.

OCTRI Research Forum: Need Patient Data? Using the OHSU Research Data Warehouse and Oregon’s All Payers, All Claims database. Oct, 20.

Join the Oregon Clinical and Translational Research Institute, OCTRI, in a monthly research forum that addresses all things clinical and translational research. Topics will be presented in a problem – solution fashion and anyone from the research arena is welcome! Do you have a clinical or translational research question or problem? Let us know and we’ll do our best to help during these events! Please submit questions and topic requests to Colleen Berreta.

Don’t miss October’s topic: Need Patient Data? Using the OHSU Research Data Warehouse and Oregon’s All Payers,  All Claims database. Presenters include Rob Schuff, John McConnell, Benjamin Chan and Stephanie Renfro.

Monday, October 20th, 2014
12-1pm at MacHall 2201

For more information about the OCTRI Research Forum please contact Colleen Berretta at 503-494-7710.

Future OCTRI Research Forum dates: Nov 10th and Dec 12th, 2014. 12-1pm at MacHall 2201. Topics TBD.

Vaccine & Gene Therapy Institute’s Jay Nelson awarded vaccine adjuvant discovery contract

Jay Nelson, director of the OHSU Vaccine & Gene Therapy Institute, has been awarded a $10 million contract from the National Institutes of Health for discovery work on new ways to improve vaccines. They were one of seven groups awarded such contracts. Vaccine adjuvants are compounds that bolster the innate immune response, essentially super-charging the vaccine. While adjuvants show great promise in improving vaccines and fighting disease, currently  just three are in use–scientists at VGTI and other institutions will begin to screen millions of molecules in search of more. Read the NIH press release here.

Orexigen featured in the Portland Business Journal

You may have read that a drug from an OHSU startup received FDA approval last month. In 2003, OHSU’s office of Technology Transfer & Business Development (TTBD) created a start-up company called Orexigen Therapeutics, Inc., with Michael Cowley, then a neuroscience researcher at the Oregon National Primate Research Center. Cowley’s work looks at the appetite-regulating pathways in the brain and how these pathways are affected by obesity. Orexigen Therapeutics became public in 2007, and now the drug based on this work, Contrave, is set to go live. Orexigen’s story was featured on the cover of the October 3rd edition of the Portland Business Journal, and you can read it HERE. (Update: we should let you know that the Business Journal article requires a subscription to read the entire article, though the link will give you a preview).

New Compass learning management system is now accepting class registrations

It’s October, and with the new month comes a new learning management system, Compass!

Compass replaces the TrainingForce online registration system across OHSU, and those of us used to searching for classes in the old system will be happy to see a more user-friendly interface. All class enrollment formerly accessed through TrainingForce can now be found in Compass. This includes research-related learning opportunities from RATE’s Essentials of Grant Administration to CRBO’s eCRIS training. Users can browse for educational topics, register for instructor-led classes, view assigned training, and eventually launch online courses.

Ready to sign up for a class? The process is simple:

  1. Open your browser and navigate to O2
  2. On the home screen, click the Compass option in your shortcut menu
  3. On the welcome screen, log in with your OHSU credentials by clicking the small “click here to log in” link located toward the top right of the screen, and NOT in the big obvious box.
  4. Type the name of the course or explore your options by using a keyword (e.g., “research”) in the search bar to the upper right.
  5. Select the desired session from the list of results
  6. Review session details and requirements
  7. To register, click “Request”.

You can search and browse for other courses by returning to the Compass home page and clicking the “browse” icon. You can then search classes by subject, date range, location, or even check out what courses are popular at OHSU. Please note that this system does not replace Big Brain–you will still go there for integrity-related classes and training.

Questions about Compass? Check out the Compass FAQ or contact the Compass support team at For questions about research-related training, contact Margaret Gardner.

Write Winning Grants: A seminar for clinician scientists, Nov. 14

John D Robertson

Presenter John D. Robertson, Ph.D.

Friday, November 14, 2014
8 a.m. to 5 p.m.
Old Library Auditorium

The Oregon Clinical and Translational Research Institute (OCTRI) is sponsoring “Write Winning Grants: A Seminar for Clinician Scientists,” on November 14, 2014. This 8-hour seminar, taking place in the Old Library Auditorium, is geared toward clinicians and scientists who wish to improve their skills in obtaining research grant funds. The seminar will address both the conceptual and practical aspects of grant writing. The cost for the seminar is $80. Payment and registration is due by October 31, 2014. The seminar agenda and registration form are available through the following link:

Please contact Kimberly Poole with any questions.

NRSA Application Workshop, Oct. 20

If you’re planning to apply for a pre- or post-doctoral NRSA fellowship from the NIH in the near future, we encourage you to attend this workshop to learn about essential, non-research elements of your fellowship application. Topics covered include elements needed for an InfoEd proposal, how to develop a budget, how to manage reference letters, biosketches and PMCID numbers,and elements of a great training plan.

This workshop is lead by Johanna Colgrove, M.D./Ph.D., program coordinator; Jerry Robertson, grants and contracts administrator; and Rachel Dresbeck, Ph.D., director of research development.

NRSA Application Workshop
Monday, October 20, 2014
2:30 to 4:30 p.m. in the Vollum Institute, 4M

Open to both researchers and administrators. Please RSVP to

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.